Patents by Inventor Michael Färber

Michael Färber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10195146
    Abstract: The present document describes a compressible delivery formulation for transmucosal delivery of at least one compound which includes a micronized powder base; and a desiccated liposome formulation comprising at least one liposome containing at least one compound, process of making the same and process for making dosage forms from the formulation.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: February 5, 2019
    Assignee: SMARTEK INTERNATIONAL LLC
    Inventor: Michael Farber
  • Publication number: 20170105959
    Abstract: Described herein are compositions and methods for enhancing or improving sexual performance or for treating sexual dysfunction or impotence comprising administering an effective amount of: a compound of formula (I): wherein n=1 to 10; wherein R1 is an amino acid side chain group (D or L configuration), or derivatives thereof, wherein R2 is a hydrogen atom, or an amino acid (D or L configuration) and derivatives thereof, forming a peptide bond; or any pharmaceutically acceptable salts thereof; and at least one a nutraceutical effective to enhance sexual performance in association with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 16, 2015
    Publication date: April 20, 2017
    Inventor: Michael Farber
  • Patent number: 9622971
    Abstract: The present document describes a compressible delivery formulation for transmucosal delivery of at least one compound which includes a micronized powder base; and a desiccated liposome formulation comprising at least one liposome containing at least one compound, process of making the same and process for making dosage forms from the formulation.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: April 18, 2017
    Assignee: SMARTEK INTERNATIONAL LLC
    Inventor: Michael Farber
  • Publication number: 20160361258
    Abstract: The present invention features a compressible delivery formulation for buccal delivery, dosage forms and methods of using the same for increasing testosterone levels in a subject. The formulation, dosage forms and methods comprise effective amounts of 3,4-divanillyltetrahydrofuran, 7-methoxyflavone, 7,8-benzoflavone, and L-Dopa.
    Type: Application
    Filed: June 10, 2015
    Publication date: December 15, 2016
    Inventor: Michael Farber
  • Publication number: 20160361257
    Abstract: The present invention features a compressible delivery formulation for buccal delivery, dosage forms and methods of using the same for increasing testosterone levels in a subject. The formulation, dosage forms and methods comprise effective amounts of 3,4-divanillyltetrahydrofuran, 7-methoxyflavone, 7,8-benzoflavone.
    Type: Application
    Filed: June 10, 2015
    Publication date: December 15, 2016
    Inventor: Michael Farber
  • Patent number: 9289356
    Abstract: A beverage container is provided for separately storing a liquid apart form an additive until mixing. The beverage container has a vessel for retaining the liquid and a compartment for retaining the additive. The vessel has an open base at an end and a release valve is connected to another end. A base coupler is connected to the open base. The compartment has a connector at each of an open end and an opposing closed end of the compartment. Connecting the closed end and the open end of the compartment to the base coupler selectively separates and mixes the liquid and the additive, respectively. The beverage container has a closure for sealing the open end of the compartment when the liquid and additive are separated. A method for separating storing and mixing a liquid and additive is also provided. A kit assembly for a beverage container is also provided.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 22, 2016
    Assignee: BOUCHE BABY INC.
    Inventors: Donna S. Farber, Mark C. Segal, Darryl Michael Farber, Michael Basara
  • Patent number: 9262940
    Abstract: Various systems to aid a visually impaired musician to learn musical notation. The system includes a microprocessor with a memory adapted to store musical notation. Multiple transducers are operatively attached to the microprocessor. The transducers are spatially located on and/or in contact with a part of the body of the visually impaired musician. Responsive to the musical notation, the microprocessor is configured to signal the transducers to provide a physical or tactile sensation to the part of the body of the visually impaired musician.
    Type: Grant
    Filed: November 27, 2014
    Date of Patent: February 16, 2016
    Inventor: Shlomo Michael Farber
  • Publication number: 20150216799
    Abstract: The present document describes a compressible delivery formulation for transmucosal delivery of at least one compound which includes a micronized powder base; and a desiccated liposome formulation comprising at least one liposome containing at least one compound, process of making the same and process for making dosage forms from the formulation.
    Type: Application
    Filed: August 16, 2013
    Publication date: August 6, 2015
    Inventor: Michael Farber
  • Publication number: 20150202175
    Abstract: The present document describes transdermal compositions comprising effective amounts of a nitric oxide amino acid ester compound, a skin penetration enhancer is association with a pharmaceutically acceptable carrier. Also described are methods of use for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation, including peripheral vascular diseases.
    Type: Application
    Filed: December 22, 2014
    Publication date: July 23, 2015
    Inventor: Michael Farber
  • Patent number: 9085508
    Abstract: There is provided amino acid ester compounds comprising at least one nitric oxide releasing group, pharmaceutically acceptable salts thereof and compositions thereof. These compounds involve an amino acid side-chain or an amino acid derivative thereof and a nitric oxide releasing group as depicted in the following structures: wherein R1 is either an ethyl or an amino acid side-chain group or an amino acid derivative thereof and R2 is an amino acid side-chain group or an amino acid derivative thereof and n is an integer from 1 to 10.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: July 21, 2015
    Assignee: Oral Delivery Technology Ltd.
    Inventor: Michael Farber
  • Patent number: 9085528
    Abstract: There is provided novel amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one amino acid ester compound comprising at least one nitric oxide releasing group, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. Also provided are compositions for increasing nitric oxide physiological levels in a subject, methods for increasing nitric oxide physiological levels in a subject, methods for improving a subject's muscle strength, athletic performances and/or lean body mass gain and or performance in a subject.
    Type: Grant
    Filed: August 13, 2010
    Date of Patent: July 21, 2015
    Assignee: Oral Delivery Technology Ltd.
    Inventor: Michael Farber
  • Publication number: 20150143975
    Abstract: Various systems to aid a visually impaired musician to learn musical notation. The system includes a microprocessor with a memory adapted to store musical notation. Multiple transducers are operatively attached to the microprocessor. The transducers are spatially located on and/or in contact with a part of the body of the visually impaired musician. Responsive to the musical notation, the microprocessor is configured to signal the transducers to provide a physical or tactile sensation to the part of the body of the visually impaired musician.
    Type: Application
    Filed: November 27, 2014
    Publication date: May 28, 2015
    Inventor: Shlomo Michael Farber
  • Publication number: 20150093338
    Abstract: There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof.
    Type: Application
    Filed: October 8, 2014
    Publication date: April 2, 2015
    Inventor: Michael Farber
  • Patent number: 8946160
    Abstract: Use of nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation, such as peripheral vascular disease. The nitric oxide amino acid esters may be co-administered with an antimicrobial in topical or transdermal compositions for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: February 3, 2015
    Assignee: Oral Delivery Technology Ltd.
    Inventor: Michael Farber
  • Patent number: 8903323
    Abstract: It is disclosed a method including creating inquiry information related to an evaluation of at least one network terminal, and transmitting the created inquiry information in a long-range reference signal; a method including receiving the inquiry information in the long-range signal, establishing, based on the received inquiry information, report information related to a quality of the long-range reference signal, and transmitting the established report information; and a method including receiving the report information, and evaluating, based on the received report information, at least one network terminal.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: December 2, 2014
    Assignee: Nokia Siemens Networks Oy
    Inventors: Martin Döttling, Michael Färber, Andreas Lobinger, Jürgen Michel, Bernhard Raaf, Ingo Viering
  • Patent number: 8883844
    Abstract: There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: November 11, 2014
    Assignee: Nitrogenix Inc.
    Inventor: Michael Farber
  • Publication number: 20140260117
    Abstract: A beverage container is provided for separately storing a liquid apart form an additive until mixing. The beverage container has a vessel for retaining the liquid and a compartment for retaining the additive. The vessel has an open base at an end and a release valve is connected to another end. A base coupler is connected to the open base. The compartment has a connector at each of an open end and an opposing closed end of the compartment. Connecting the closed end and the open end of the compartment to the base coupler selectively separates and mixes the liquid and the additive, respectively. The beverage container has a closure for sealing the open end of the compartment when the liquid and additive are separated. A method for separating storing and mixing a liquid and additive is also provided. A kit assembly for a beverage container is also provided.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Donna S. FARBER, Mark C. SEGAL, Darryl Michael FARBER, Michael BASARA
  • Publication number: 20140227342
    Abstract: The present document describes a composition containing an effective amount of an acetylcholinesterase inhibitor, a solvent, and a permeation enhancer in a pharmaceutically acceptable carrier, and uses thereof.
    Type: Application
    Filed: March 12, 2013
    Publication date: August 14, 2014
    Inventor: Michael Farber
  • Publication number: 20140148438
    Abstract: There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof.
    Type: Application
    Filed: September 22, 2011
    Publication date: May 29, 2014
    Inventor: Michael Farber
  • Patent number: D716099
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 28, 2014
    Assignee: Bouche Baby Inc.
    Inventors: Donna S. Farber, Mark C. Segal, Darryl Michael Farber, Michael Basara